Is Sarepta Therapeutics, Inc. (SRPT) a Buy, Sell, or Hold?
NASDAQ : SRPT
Sarepta Therapeutics, Inc.
$17.61 USD
-$0.35 (-1.95%)
- Volume
- 3.46M
- Average Volume
- 3.29M
- Market Capitalization
- $1.86B
- P/E Ratio
- 28.40
- Dividend Yield
- 0.00%
- Price Target
- $25.00
- Year High
- $25.32
- Year Low
- $10.42
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.63
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
34
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
32
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$88044
SRPT Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
SRPT Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Boor Kathryn Jean | director | 2026-06-04 | A-Award | 0 | 2026-06-05 |
| Mayo Stephen | director | 2026-06-04 | A-Award | 0 | 2026-06-05 |
| Wigzell Hans Lennart Rudolf | director | 2026-06-04 | A-Award | 0 | 2026-06-05 |
| BEHRENS M KATHLEEN | director | 2026-06-04 | A-Award | 0 | 2026-06-05 |
| Connelly Deirdre P | director | 2026-06-04 | A-Award | 0 | 2026-06-05 |
| Nicaise Claude | director | 2026-06-04 | A-Award | 0 | 2026-06-05 |
| Chambers Michael Andrew | director | 2026-06-04 | A-Award | 0 | 2026-06-05 |
| Barry Richard | director | 2026-06-04 | A-Award | 0 | 2026-06-05 |
| Estepan Ian Michael | officer: Chief Operating Officer | 2026-03-11 | F-InKind | 17.03 | 2026-03-13 |
| Wong Ryan Ho-Yan | officer: Chief Financial Officer | 2026-03-11 | F-InKind | 17.03 | 2026-03-13 |
| Rodino-Klapac Louise | officer: President, R&D and Tech Ops | 2026-03-11 | F-InKind | 17.03 | 2026-03-13 |
| Mayo Stephen | director | 2026-03-12 | S-Sale | 17.02 | 2026-03-13 |
| Rothfuss Cristin | officer: EVP, General Counsel | 2026-03-11 | F-InKind | 17.03 | 2026-03-13 |
| Wong Ryan Ho-Yan | officer: Chief Financial Officer | 2026-03-09 | F-InKind | 16.95 | 2026-03-11 |
| Wong Ryan Ho-Yan | officer: Chief Financial Officer | 2026-03-09 | F-InKind | 16.95 | 2026-03-11 |
| Rothfuss Cristin | officer: EVP, General Counsel | 2026-03-09 | F-InKind | 16.95 | 2026-03-11 |
| Rothfuss Cristin | officer: EVP, General Counsel | 2026-03-09 | F-InKind | 16.95 | 2026-03-11 |
| Rodino-Klapac Louise | officer: President, R&D and Tech Ops | 2026-03-09 | F-InKind | 16.95 | 2026-03-11 |
| Rodino-Klapac Louise | officer: President, R&D and Tech Ops | 2026-03-09 | F-InKind | 16.95 | 2026-03-11 |
| Estepan Ian Michael | officer: Chief Operating Officer | 2026-03-09 | F-InKind | 16.95 | 2026-03-11 |
| Estepan Ian Michael | officer: Chief Operating Officer | 2026-03-09 | F-InKind | 16.95 | 2026-03-11 |
| Rothfuss Cristin | officer: EVP, General Counsel | 2026-03-02 | F-InKind | 16.2 | 2026-03-03 |
| Wong Ryan Ho-Yan | officer: Chief Financial Officer | 2026-03-02 | F-InKind | 16.2 | 2026-03-03 |
| Estepan Ian Michael | officer: Chief Operating Officer | 2026-03-01 | M-Exempt | 0 | 2026-03-03 |
| Estepan Ian Michael | officer: Chief Operating Officer | 2026-03-02 | F-InKind | 16.2 | 2026-03-03 |
| Estepan Ian Michael | officer: Chief Operating Officer | 2026-03-02 | F-InKind | 16.2 | 2026-03-03 |
| Estepan Ian Michael | officer: Chief Operating Officer | 2026-03-01 | M-Exempt | 0 | 2026-03-03 |
| Rodino-Klapac Louise | officer: President, R&D and Tech Ops | 2026-03-01 | M-Exempt | 0 | 2026-03-03 |
| Rodino-Klapac Louise | officer: President, R&D and Tech Ops | 2026-03-02 | F-InKind | 16.2 | 2026-03-03 |
| Rodino-Klapac Louise | officer: President, R&D and Tech Ops | 2026-03-02 | F-InKind | 16.2 | 2026-03-03 |
| Rodino-Klapac Louise | officer: President, R&D and Tech Ops | 2026-03-01 | M-Exempt | 0 | 2026-03-03 |
| Estepan Ian Michael | officer: Chief Operating Officer | 2026-02-26 | M-Exempt | 13.71 | 2026-03-02 |
| Estepan Ian Michael | officer: Chief Operating Officer | 2026-02-26 | M-Exempt | 13.71 | 2026-03-02 |
| Estepan Ian Michael | officer: Chief Operating Officer | 2026-02-26 | M-Exempt | 13.71 | 2026-03-02 |
| Estepan Ian Michael | officer: Chief Operating Officer | 2026-02-25 | A-Award | 0 | 2026-02-27 |
| Rodino-Klapac Louise | officer: President, R&D and Tech Ops | 2026-02-25 | A-Award | 0 | 2026-02-27 |
| Nicaise Claude | director | 2026-01-29 | M-Exempt | 13.71 | 2026-01-29 |
| Nicaise Claude | director | 2026-01-29 | F-InKind | 21.23 | 2026-01-29 |
| Nicaise Claude | director | 2026-01-29 | M-Exempt | 13.71 | 2026-01-29 |
| BEHRENS M KATHLEEN | director | 2026-01-27 | M-Exempt | 13.71 | 2026-01-29 |
| BEHRENS M KATHLEEN | director | 2026-01-27 | F-InKind | 22.17 | 2026-01-29 |
| BEHRENS M KATHLEEN | director | 2026-01-27 | M-Exempt | 13.71 | 2026-01-29 |
| Chambers Michael Andrew | director | 2025-12-18 | A-Award | 60 | 2025-12-19 |
| Chambers Michael Andrew | director | 2025-12-18 | D-Return | 141.97 | 2025-12-19 |
| Estepan Ian Michael | officer: Chief Operating Officer | 2025-12-16 | S-Sale | 22.31 | 2025-12-18 |
| Wong Ryan Ho-Yan | officer: Chief Financial Officer | 2025-12-01 | F-InKind | 20.96 | 2025-12-10 |
| Wong Ryan Ho-Yan | officer: Chief Financial Officer | 2025-12-01 | F-InKind | 20.96 | 2025-12-10 |
| INGRAM DOUGLAS S | director, officer: Chief Executive Officer | 2025-12-07 | A-Award | 0 | 2025-12-09 |
| INGRAM DOUGLAS S | director, officer: Chief Executive Officer | 2025-12-07 | A-Award | 0 | 2025-12-09 |
| INGRAM DOUGLAS S | director, officer: Chief Executive Officer | 2025-12-07 | A-Award | 0 | 2025-12-09 |
| INGRAM DOUGLAS S | director, officer: Chief Executive Officer | 2025-12-07 | A-Award | 0 | 2025-12-09 |
| INGRAM DOUGLAS S | director, officer: Chief Executive Officer | 2025-12-07 | A-Award | 0 | 2025-12-09 |
| Rothfuss Cristin | officer: EVP, General Counsel | 2025-11-28 | F-InKind | 21.12 | 2025-12-02 |
| Rodino-Klapac Louise | officer: President, R&D and Tech Ops | 2025-11-17 | F-InKind | 18.42 | 2025-11-19 |
| Rodino-Klapac Louise | officer: President, R&D and Tech Ops | 2025-09-03 | A-Award | 0 | 2025-09-05 |
| Rodino-Klapac Louise | officer: President, R&D and Tech Ops | 2025-09-03 | A-Award | 0 | 2025-09-05 |
| Wong Ryan Ho-Yan | officer: Chief Financial Officer | 2025-09-03 | A-Award | 0 | 2025-09-05 |
| Wong Ryan Ho-Yan | officer: Chief Financial Officer | 2025-09-03 | A-Award | 0 | 2025-09-05 |
| Estepan Ian Michael | officer: Chief Operating Officer | 2025-09-03 | A-Award | 0 | 2025-09-05 |
| Estepan Ian Michael | officer: Chief Operating Officer | 2025-09-03 | A-Award | 0 | 2025-09-05 |
| Rothfuss Cristin | officer: EVP, General Counsel | 2025-09-03 | A-Award | 0 | 2025-09-05 |
| Rothfuss Cristin | officer: EVP, General Counsel | 2025-09-03 | A-Award | 0 | 2025-09-05 |
| Arif Bilal | officer: Chief Tech Ops Officer | 2025-08-05 | A-Award | 0 | 2025-08-06 |
| Estepan Ian Michael | officer: Chief Operating Officer | 2025-08-05 | A-Award | 0 | 2025-08-06 |
| Rodino-Klapac Louise | officer: President, R&D and Tech Ops | 2025-08-05 | A-Award | 0 | 2025-08-06 |
| Wong Ryan Ho-Yan | officer: Chief Financial Officer | 2025-07-31 | F-InKind | 16.42 | 2025-08-04 |
| Wong Ryan Ho-Yan | officer: Chief Financial Officer | 2025-07-16 | 0 | 2025-08-04 | |
| Wong Ryan Ho-Yan | officer: Chief Financial Officer | 2023-03-07 | 80.42 | 2025-08-04 | |
| Wong Ryan Ho-Yan | officer: Chief Financial Officer | 2023-11-30 | 122.81 | 2025-08-04 | |
| Wong Ryan Ho-Yan | officer: Chief Financial Officer | 2025-03-01 | 128.67 | 2025-08-04 | |
| Wong Ryan Ho-Yan | officer: Chief Financial Officer | 2026-03-10 | 99.69 | 2025-08-04 | |
| Wong Ryan Ho-Yan | officer: Chief Financial Officer | 2022-07-31 | 67.78 | 2025-08-04 | |
| Wong Ryan Ho-Yan | officer: Chief Financial Officer | 2024-03-06 | 155.99 | 2025-08-04 | |
| Barry Richard | director | 2025-05-16 | M-Exempt | 32.63 | 2025-05-19 |
| Barry Richard | director | 2025-05-16 | M-Exempt | 32.63 | 2025-05-19 |
| Barry Richard | director | 2025-05-13 | M-Exempt | 13.71 | 2025-05-15 |
| Barry Richard | director | 2025-05-13 | M-Exempt | 25.18 | 2025-05-15 |
| Barry Richard | director | 2025-05-13 | M-Exempt | 13.71 | 2025-05-15 |
| Barry Richard | director | 2025-05-13 | M-Exempt | 25.18 | 2025-05-15 |
| Nicaise Claude | director | 2025-03-12 | M-Exempt | 25.18 | 2025-03-13 |
| Nicaise Claude | director | 2025-03-12 | S-Sale | 99.64 | 2025-03-13 |
| Nicaise Claude | director | 2025-03-12 | M-Exempt | 25.18 | 2025-03-13 |
| Connelly Deirdre P | director | 2025-03-10 | A-Award | 0 | 2025-03-11 |
| Connelly Deirdre P | director | 2025-03-10 | A-Award | 99.69 | 2025-03-11 |
| Boor Kathryn Jean | director | 2025-03-10 | A-Award | 0 | 2025-03-11 |
| Boor Kathryn Jean | director | 2025-03-10 | A-Award | 99.69 | 2025-03-11 |
| Chambers Michael Andrew | director | 2025-03-10 | A-Award | 0 | 2025-03-11 |
| Chambers Michael Andrew | director | 2025-03-10 | A-Award | 99.69 | 2025-03-11 |
| Estepan Ian Michael | officer: Chief Financial Officer | 2025-03-10 | A-Award | 0 | 2025-03-11 |
| Estepan Ian Michael | officer: Chief Financial Officer | 2025-03-07 | M-Exempt | 0 | 2025-03-11 |
| Estepan Ian Michael | officer: Chief Financial Officer | 2025-03-10 | F-InKind | 100.13 | 2025-03-11 |
| Estepan Ian Michael | officer: Chief Financial Officer | 2025-03-10 | F-InKind | 100.13 | 2025-03-11 |
| Rothfuss Cristin | officer: EVP, General Counsel | 2025-03-10 | A-Award | 0 | 2025-03-11 |
| Estepan Ian Michael | officer: Chief Financial Officer | 2025-03-10 | A-Award | 99.69 | 2025-03-11 |
| Rothfuss Cristin | officer: EVP, General Counsel | 2025-03-10 | A-Award | 99.69 | 2025-03-11 |
| Rothfuss Cristin | officer: EVP, General Counsel | 2025-03-10 | F-InKind | 100.13 | 2025-03-11 |
| Estepan Ian Michael | officer: Chief Financial Officer | 2025-03-07 | M-Exempt | 0 | 2025-03-11 |
| Wigzell Hans Lennart Rudolf | director | 2025-03-10 | A-Award | 0 | 2025-03-11 |
| Wigzell Hans Lennart Rudolf | director | 2025-03-10 | A-Award | 99.69 | 2025-03-11 |
| Mayo Stephen | director | 2025-03-10 | A-Award | 0 | 2025-03-11 |